IH636 Grape Seed Extract
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for IH636 Grape Seed Extract, covering 2013-11-06 to 2015-06-08. Get the full timeline:
Most recent: Clinical Trial Update: IH636 Grape Seed Extract in Preventing Breast Cancer in Postmenopausal Women at Risk of Developing Breast Cancer [Phase 1]